Inhaled nitric oxide in the treatment of preterm infants.
Inhaled nitric oxide (iNO) has been used successfully in select term and near-term infants with respiratory failure. The use of iNO in the premature infant population, however, remains controversial. This article will review some of the current literature regarding the use of iNO in premature infants and discuss current recommendations and future research directions.
Miller
Stephanie S
SS
Department of Pediatrics, Lucile Packard Children's Hospital at Stanford University, Stanford, CA, United States. ssmith97@stanford.edu
Rhine
William D
WD
D000280:Administration, Inhalation; D000818:Animals; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D008171:Lung Diseases / Q000188:drug therapy*; D009569:Nitric Oxide / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic
D001993:Bronchodilator Agents; D009569:Nitric Oxide